Philip Philip, MD
Medical Oncology · Detroit, MINPI 1316985484
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 19.9%. Reporting peaked in 2021 at $120,281 and has fallen 84.4% since, to $18,767 in 2025. Among medical oncology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 405 payments — averaging $1219.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$98K
- Bayer$60K
- AstraZeneca$55K
- Trisalus Life Sciences, Inc.$40K
- Biontech SE$34K
- Bristol Myers Squibb$28K
- plus $179K from 34 others
Across 367 payments — averaging $2386.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Taiho Oncology, Inc.$150K
- Incyte Corporation$128K
- Merck$84K
- Geistlich Pharma, North America, Inc.$72K
- Corcept Therapeutics$64K
- Novartis$59K
- plus $319K from 14 others
What the payments were for
- Consulting fees$188,30838%
- Speaking & faculty fees$220,43845%
- Travel & lodging$73,81115%
- Food & beverage$9,5922%
- Education$1,9070%
- Gifts$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$494,086 in reported general payments places this provider in the 95th percentile of 170 medical oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Detroit
- Shirish GadgeelDetroit$413K
- Patricia Lo RussoDetroit$322K
- Ammar SukariDetroit$273K
- Charles SchifferDetroit$165K
- Ahmed KasebDetroit$107K
- Bassel El-RayesDetroit$76K
- Haythem AliDetroit$34K
- Dipesh UpretyDetroit$21K
- Clara HwangDetroit$16K
- Amy WeiseDetroit$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.